RTI Biologics, Inc.
Stock Ticker
Join IR Rolodex

Annual Financial Results

(in thousands, except per share data)

  Year Ended
Dec. 31, 2004
Year Ended
Dec. 31, 2005
Year Ended
Dec. 31, 2006
Year Ended
Dec. 31, 2007
9 Months Ending
Sept. 30, 2008
Net Revenues 92,703 75,199 73,970 94,207 109,272
Gross Profit 37, 177 19,742 19,323 37,650 51,159
Operating (Loss) Income 9,979 (8,947) (17,534) (2,568) 4,160
Net (Loss) Income Per Share          
Basic 0.23 (0.20) (0.37) (0.07) 0.05
Diluted 0.23 (0.20) (0.37) (0.07) 0.05
Current Assets 69,114 85,343 73,301 88,442 122,834
Total Assets 124,730 142,310 129,808 136,326 426,045
Total Stockholders’ Equity 99,602 117,813 109,890 111,643 383,126
Web Design by 352 Media Group®. Copyright ©2006 RTI Biologics, Inc. All Rights Reserved. Privacy Policy.